Targeting NETs using dual-active DNase1 variants.
Englert H, Göbel J, Khong D, Omidi M, Wolska N, Konrath S, Frye M, Mailer RK, Beerens M, Gerwers JC, Preston RJS, Odeberg J, Butler LM, Maas C, Stavrou EX, Fuchs TA, Renné T.
Englert H, et al. Among authors: beerens m.
Front Immunol. 2023 May 23;14:1181761. doi: 10.3389/fimmu.2023.1181761. eCollection 2023.
Front Immunol. 2023.
PMID: 37287977
Free PMC article.